this post was submitted on 09 Sep 2023
89 points (100.0% liked)
U.S. News
2277 readers
139 users here now
News about and pertaining to the United States and its people.
Please read what's functionally the mission statement before posting for the first time. We have a narrower definition of news than you might be accustomed to.
Guidelines for submissions:
- Post the original source of information as the link.
- Corporate- and billionaire-owned media is no longer accepted as a news source.
- If there is any Nazi imagery in the linked story, mark your post NSFW.
- Advocating violence is not allowed on Beehaw in general.
- If there is a paywall, provide an archive link in the body.
- Post using the original headline; edits for clarity (as in providing crucial info a clickbait hed omits) are fine.
- Social media is not a news source.
For World News, see the News community.
This community's icon was made by Aaron Schneider, under the CC-BY-NC-SA 4.0 license.
founded 2 years ago
MODERATORS
you are viewing a single comment's thread
view the rest of the comments
view the rest of the comments
I don't know much about the opioid shortage, but for Adderall it seems to be more complicated than just the quotas.... https://www.bloomberg.com/news/newsletters/2023-02-28/are-adderall-dea-quotas-contributing-to-the-shortage
If a manufacturer asks for an increased quota and the DEA denies it, they have to do so publicly, with a notice. Guess what, no notices.
Another source:
https://www.livemint.com/news/world/whats-behind-shortages-of-adderall-ozempic-and-other-meds-in-us-11682897998433.html
And another https://www.painnewsnetwork.org/stories/2023/8/3/fda-and-dea-leaders-call-for-more-adhd-meds-but-ignore-rx-opioid-shortages